Large
accelerated filer
|
o
|
Accelerated
filer
|
o
|
|
Non-accelerated
filer
|
o
|
Smaller
reporting company
|
R
|
MATERIAL
TECHNOLOGIES, INC.
|
||||
(A
Development Stage Company)
|
||||
CONDENSED
CONSOLIDATED BALANCE SHEET
|
||||
June
30,
|
||||
2008
|
||||
(Unaudited)
|
||||
ASSETS
|
||||
Current
assets:
|
||||
Cash
and cash equivalents
|
$ | 530,045 | ||
Inventories
|
148,964 | |||
Prepaid
expenses and other current assets
|
62,941 | |||
Total
current assets
|
741,950 | |||
Property
and equipment, net
|
89,632 | |||
Intangible
assets, net
|
2,302 | |||
Deposit
|
2,348 | |||
$ | 836,232 |
MATERIAL
TECHNOLOGIES, INC.
|
||||
(A
Development Stage Company)
|
||||
CONDENSED
CONSOLIDATED BALANCE SHEET - Continued
|
||||
June
30,
|
||||
2008
|
||||
(Unaudited)
|
||||
(Restated)
|
||||
LIABILITIES
AND STOCKHOLDERS' DEFICIT
|
||||
Current
liabilities:
|
||||
Accounts
payable and accrued expenses
|
$ | 470,017 | ||
Current
portion of research and development sponsorship payable
|
25,000 | |||
Notes
payable
|
67,573 | |||
Total
current liabilities
|
562,590 | |||
Accrued
legal settlement
|
250,000 | |||
Research
and development sponsorship payable, net of current
portion
|
784,100 | |||
Convertible
debentures and accrued interest payable, net of discount
|
270,973 | |||
Notes
payable, long-term
|
222,110 | |||
Derivative
and warrant liabilities
|
75,760,425 | |||
77,287,608 | ||||
Total
liabilities
|
77,850,198 | |||
Minority
interest in consolidated subsidiary
|
825 | |||
Commitments
and contingencies
|
||||
Stockholders'
deficit:
|
||||
Class
A preferred stock, $0.001 par value, liquidation
preference
|
||||
of $720
per share; 350,000 shares authorized; 337 shares issued
|
||||
and
outstanding as of June 30, 2008
|
- | |||
Class
B preferred stock, $0.001 par value, liquidation preference
of
|
||||
$10,000
per share; 15 shares authorized; none issued
and
|
||||
outstanding
as of June 30, 2008
|
- | |||
Class
C preferred stock, $0.001 par value, liquidation preference
of
|
||||
$0.001
per share; 25,000,000 shares authorized; 1,517 shares
issued
|
||||
and
outstanding as of June 30,2008
|
1 | |||
Class
D preferred stock, $0.001 par value, liquidation preference
of
|
||||
$0.001
per share; 20,000,000 shares authorized; none shares
issued
|
||||
and
outstanding as of June 30,2008
|
- | |||
Class
E convertible preferred stock, $0.001 par value, no
liquidation
|
||||
preference;
60,000 shares authorized; 53,700 shares issued and
|
||||
outstanding
as of June 30,2008
|
54 | |||
Class
A Common Stock, $0.001 par value, 600,000,000 shares
|
||||
authorized;
168,499 shares issued and 149,330 shares outstanding
|
||||
at
June 30,2008
|
149 | |||
Class
B Common Stock, $0.001 par value, 600,000 shares
authorized,
|
||||
issued
and outstanding as of June 30,2008
|
600 | |||
Warrants
subscribed
|
10,000 | |||
Additional
paid-in-capital
|
326,904,859 | |||
Deficit
accumulated during the development stage
|
(403,834,055 | ) | ||
Treasury
stock ( 293 shares at cost at June 30, 2008)
|
(96,399 | ) | ||
Total
stockholders' deficit
|
(77,014,791 | ) | ||
$ | 836,232 |
MATERIAL
TECHNOLOGIES, INC.
|
||||||||||||||||||||
(A
Development Stage Company)
|
||||||||||||||||||||
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
|
||||||||||||||||||||
From
October 21, 1983
|
||||||||||||||||||||
For
the Three Months Ended
|
For
the Six Months Ended
|
(Inception)
|
||||||||||||||||||
June
30,
|
June
30,
|
through
|
||||||||||||||||||
2007
|
2008
|
2007
|
2008
|
June
30, 2008
|
||||||||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||||||||
(Restated)
|
(Restated)
|
(Restated)
|
||||||||||||||||||
Revenues:
|
||||||||||||||||||||
Research
and development
|
$ | - | $ | - | $ | - | $ | - | $ | 5,392,085 | ||||||||||
Revenue
from bridge testing
|
22,778 | 66,745 | 1,090 | 319,714 | ||||||||||||||||
Other
|
- | - | - | - | 274,125 | |||||||||||||||
Total
revenues
|
22,778 | - | 66,745 | 1,090 | 5,985,924 | |||||||||||||||
Costs
and expenses:
|
||||||||||||||||||||
Research
and development
|
3,294,575 | 150,847 | 3,512,076 | 309,840 | 20,872,829 | |||||||||||||||
General
and administrative
|
41,016,474 | 5,517,443 | 62,475,638 | 25,845,768 | 329,341,009 | |||||||||||||||
Modification
of research and development sponsorship agreement
|
- | - | - | - | 5,963,120 | |||||||||||||||
Loss
on settlement of lawsuits
|
- | - | - | - | 1,267,244 | |||||||||||||||
Total
costs and expenses
|
44,311,049 | 5,668,290 | 65,987,714 | 26,155,608 | 357,444,202 | |||||||||||||||
Loss
from operations
|
(44,288,271 | ) | (5,668,290 | ) | (65,920,969 | ) | (26,154,518 | ) | (351,458,278 | ) | ||||||||||
Other
income (expense):
|
||||||||||||||||||||
Loss
on modification of convertible debt
|
- | (964,730 | ) | - | (964,730 | ) | (378,485 | ) | ||||||||||||
Loss
on subcription receivables
|
(1,368,555 | ) | ||||||||||||||||||
Interest
expense
|
(612,416 | ) | (606,028 | ) | (1,590,651 | ) | (977,019 | ) | (12,717,212 | ) | ||||||||||
Other-than-temporary
impairment of marketable securities available for
sale
|
- | (9,785,947 | ) | |||||||||||||||||
Net
unrealized and realized loss of marketable securities
|
(8,556,211 | ) | (8,556,219 | ) | (8 | ) | (9,398,226 | ) | ||||||||||||
Change
in fair value of investments derivative liability
|
- | - | - | - | (210,953 | ) | ||||||||||||||
Change
in fair value of derivative and warrant liabilities
|
6,942,597 | (71,103,676 | ) | 22,920,017 | (62,544,101 | ) | (18,957,012 | ) | ||||||||||||
Interest
income
|
12,594 | 3,080 | 15,966 | 15,523 | 482,405 | |||||||||||||||
Other
|
- | - | - | - | (25,992 | ) | ||||||||||||||
Other
income (expense), net
|
(2,213,436 | ) | (72,671,354 | ) | 12,789,113 | (64,470,335 | ) | (52,359,977 | ) | |||||||||||
Loss
before provision for income taxes
|
(46,501,707 | ) | (78,339,644 | ) | (53,131,856 | ) | (90,624,853 | ) | (403,818,255 | ) | ||||||||||
Provision
for income taxes
|
- | - | (800 | ) | (800 | ) | (15,800 | ) | ||||||||||||
Net
loss
|
$ | (46,501,707 | ) | $ | (78,339,644 | ) | $ | (53,132,656 | ) | $ | (90,625,653 | ) | $ | (403,834,055 | ) | |||||
Per
share data:
|
||||||||||||||||||||
Basic
and diluted net loss per share
|
$ | (448.38 | ) | $ | (500.20 | ) | $ | (580.45 | ) | $ | (614.04 | ) | ||||||||
Weighted
average Class A common shares outstanding - basic and
diluted
|
103,710 | 156,617 | 91,538 | 147,589 |
MATERIAL
TECHNOLOGIES, INC.
|
||||||||||||
(A
Development Stage Company)
|
||||||||||||
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
||||||||||||
From
October 21, 1983
|
||||||||||||
For
the Six Months Ended
|
(Inception)
|
|||||||||||
June
30,
|
through
|
|||||||||||
2007
|
2008
|
June
30, 2008
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
(Restated)
|
(Restated)
|
|||||||||||
Cash
flows from operating activities:
|
||||||||||||
Net
loss
|
$ | (53,132,656 | ) | $ | (90,625,653 | ) | $ | (403,834,055 | ) | |||
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
||||||||||||
Loss
on modification of convertible debt
|
- | 964,730 | 378,485 | |||||||||
Impairment
loss
|
19,255,875 | - | 21,391,528 | |||||||||
Loss
on charge off of subscription receivables
|
- | 1,368,555 | ||||||||||
Issuance
of common stock for services
|
15,558,944 | 3,625,200 | 210,110,040 | |||||||||
Increase
in debt for services and fees
|
- | 1,100,000 | 5,556,625 | |||||||||
Officer's
stock based compensation
|
30,000,000 | 19,885,333 | 86,460,675 | |||||||||
Issuance
of common stock for modification of research and development
sponsorship agreement
|
- | 7,738,400 | ||||||||||
Change
in fair value of derivative and warrant liabilities
|
(41,351,889 | ) | ||||||||||
Net
realized and unrealized loss on marketable securities
|
8,556,200 | 7,895,705 | ||||||||||
Other-than-temporary
impairment of marketable securities available for
sale
|
- | 9,785,946 | ||||||||||
Legal
fees incurred for note payable
|
1,456,142 | |||||||||||
Accrued
interest expense added to principal
|
156,901 | 135,816 | 1,630,821 | |||||||||
Amortization
of discount on convertible debentures
|
1,431,081 | 824,072 | 10,930,350 | |||||||||
Change
in fair value of investments derivative liability
|
(22,920,017 | ) | 62,544,101 | 65,767,423 | ||||||||
Accrued
interest income added to principal
|
(5,428 | ) | 25,433 | (279,565 | ) | |||||||
Depreciation
and amortization
|
1,951 | 10,621 | 238,405 | |||||||||
Other
non-cash adjustments
|
- | (114,730 | ) | |||||||||
(Increase)
decrease in trade receivables
|
91,787 | 108,661 | (50,328 | ) | ||||||||
(Increase)
decrease in inventories
|
- | (86,748 | ) | (148,964 | ) | |||||||
(Increase)
decrease in prepaid expenses and other current
assets
|
(22,500 | ) | (17,257 | ) | 225,316 | |||||||
Increase
in deposits
|
- | (2,348 | ) | |||||||||
(Decrease)
increase in accounts payable and
accrued expenses
|
(141,766 | ) | (130,968 | ) | 2,377,927 | |||||||
Net
cash used in operating activities
|
(1,169,628 | ) | (1,636,659 | ) | (12,469,536 | ) | ||||||
Cash
flows from investing activities:
|
||||||||||||
Proceeds
from the sale of marketable securities
|
95,006 | 300,000 | 3,758,476 | |||||||||
Purchase
of marketable securities
|
(302,038 | ) | - | (2,206,379 | ) | |||||||
Investment
in certificate of deposits and commerical paper
|
(700,177 | ) | (565,000 | ) | (1,965,000 | ) | ||||||
Maturities
of certificate of deposits and commercial paper
|
- | 1,565,000 | 1,965,000 | |||||||||
Payment
received on officer loans
|
- | 3,803 | 880,058 | |||||||||
Funds
advanced to officers
|
- | - | (549,379 | ) | ||||||||
Proceeds
received in acquisition of consolidated subsidiaries
|
600,000 | |||||||||||
Purchase
of property and equipment
|
- | (17,167 | ) | (373,419 | ) | |||||||
Investment
in joint ventures
|
- | - | (102,069 | ) | ||||||||
Proceeds
from foreclosure
|
- | - | 44,450 | |||||||||
Proceeds
from the sale of property and equipment
|
- | - | 19,250 | |||||||||
Payment
for license agreement
|
- | - | (6,250 | ) | ||||||||
Net
cash provided by (used in) investing activities
|
(907,209 | ) | 1,286,636 | 2,064,738 |
MATERIAL
TECHNOLOGIES, INC.
|
||||||||||||
(A
Development Stage Company)
|
||||||||||||
CONSOLIDATED
STATEMENTS OF CASH FLOWS - Continued
|
||||||||||||
From
October 21, 1983
|
||||||||||||
For
the Six Months Ended
|
(Inception)
|
|||||||||||
June
30,
|
through
|
|||||||||||
2007
|
2008
|
June
30, 2008
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
(Restated)
|
(Restated)
|
|||||||||||
Cash
flow from financing activities:
|
||||||||||||
Proceeds
from the sale of common stock and warrants
|
$ | 2,850,000 | $ | 18,624 | $ | 9,464,577 | ||||||
Proceeds
from convertible debentures and other notes payable
|
200,000 | 55,000 | 2,102,766 | |||||||||
Proceeds
from the sale of preferred stock
|
100,000 | - | 473,005 | |||||||||
Costs
incurred in offerings
|
(773,779 | ) | - | (1,130,932 | ) | |||||||
Capital
contributions
|
- | - | 301,068 | |||||||||
Purchase
of treasury stock
|
(17,381 | ) | (3,266 | ) | (170,641 | ) | ||||||
Principal
reduction on notes payable
|
(26,671 | ) | (100,000 | ) | ||||||||
Payment
on proposed reorganization
|
- | - | (5,000 | ) | ||||||||
Net
cash provided by (used in) financing activities
|
2,332,169 | 70,358 | 10,934,843 | |||||||||
Net
change in cash and cash equivalents
|
255,332 | (279,665 | ) | 530,045 | ||||||||
Cash
and cash equivalents, beginning of period
|
129,296 | 809,710 | - | |||||||||
Cash
and cash equivalents, end of period
|
$ | 384,628 | $ | 530,045 | $ | 530,045 | ||||||
Supplemental
disclosure of cash flow information:
|
||||||||||||
Interest
paid during the period
|
$ | 2,669 | $ | 281 | ||||||||
Income
taxes paid during the period
|
$ | 800 | $ | 800 |
Supplemental
disclosures of non-cash investing and financing
activities:
|
||||||||
2008
|
||||||||
During
the six months ended June 30, 2008, the Company issued 4,230 shares of its
Class A common shares in
|
||||||||
the
conversion of $491,132 of convertible debt.
|
||||||||
During
the six months ended June 30, 2008, the Company issued 13,207 shares of
its Class A common stock
|
||||||||
for
consulting services valued at $3,668,400.
|
||||||||
During
the six months ended June 30, 2008, the Company issued 378 shares of its
Class A common stock
|
||||||||
pursuant
to the anti-dilution provisions of a settlement
agreement.
|
||||||||
During
the six months ended June 30, 2008. a former employee returned 450 shares
of the Company's Class A
|
||||||||
common
stock to treasury which were subsequently cancelled.
|
||||||||
During
the six months ended June 30, 2008. the Company's president returned
30,000 shares of the Company's
|
||||||||
Class
A common stock to treasury which were subsequently
cancelled.
|
||||||||
During
the six months ended June 30, 2008, the Company issued 34,500 shares of
its Class A common stock
|
||||||||
in
consideration of the exercise of cashless warrants. The Company accrued
derivative liability in connection with the
|
||||||||
granting
of the warrants, which had a balance of $1,151,900 on the date of
exercise. The liability balance was credited to equity.
|
||||||||
During
the six months ended June 30, 2008, the Company issued 78 shares of its
Class A common stock for $18,624.
|
||||||||
During
the six months ended June 30, 2008, the Company issued 1,040 shares of the
Company's common stock
|
||||||||
was
issued through the conversion of 1,300 shares of the Company's Class E
preferred shares.
|
||||||||
During
the six months ended June 30, 2008, the Company contingent obligation to
Mr. Beck under a settlement agreement
|
||||||||
was
reduced to $0, therefore the Company reduced its legal settlement
liability by the remaining accrued provision of
$230,000,
|
||||||||
which
was credited to equity.
|
||||||||
During
the six months ended June 30, 2008, the Company obtained $55,000 through
the issuance of convertible debt. In connection
|
||||||||
with
this debt, the Company recognized a beneficial conversion feature of
$28,140 that was credited to
equity.
|
During
the six months ended June 30, 2008, the Company recognized compensation
expense of $8,800 on the grant of
|
||||||||
options
to its employees and officers for the purchase of 800.000 shares of Class
A common stock. In addition, during the six months
|
||||||||
the
Company granted options to its President for the purchase of 400,000,000
shares of its Class A common stock and granted
options
|
||||||||
to
a consultant to purchase 15,390,546 shares of its Class A common stock.
The Company recognized a derivative liability of
$6,400,000
|
||||||||
on
the granting of these options.
|
||||||||
2007
|
||||||||
During
the six months ended June 30, 2007, the Company issued 2,839 shares of its
Class A common stock
|
||||||||
for
consulting services valued at $13,158,944.
|
||||||||
During
the six months ended June 30, 2007, the Company received $1,000,000 in
consideration of issuing 2,500 units.
|
||||||||
Each
unit consists of one share of the Company's Class A common stock and a
warrant to purchase
|
||||||||
one
share of the Company's common stock at a price of $.60 per share. In
connection with the private offering
|
||||||||
the
Company paid $239,065 in fees and issued warrants to purchase 2,118 shares
of the Company's
|
||||||||
common
stock at a price of $1.20 per share.
|
||||||||
During
the six months ended June 30, 2007, the Company issued 50,000 shares its
Class E Series convertible
|
||||||||
preferred
stock in exchange for receiving all of the outstanding shares of Stress
Analysis Technologies, Inc. ("SATI").
|
||||||||
The
Company valued the acquisition at $19,355,875 of which $19,255,875 was
allocated to the acquired license.
|
||||||||
Durng
the six months ended June 30, 2007, the Company deemed the license to be
impaired and charged of the
|
||||||||
$19,255,875
to operation. In connection with this transaction, the Company issued an
additional 5,000 preferred
|
||||||||
shares
valued at $2,400,000 for fees in connection with the purchase. The
$2,400,000 was charged to operations.
|
||||||||
During
the six months ended June 30, 2007, the Company issued 10,800
shares in escrow pursuant to an agreement it has with
|
||||||||
with
its convertible debenture holders. During 2007, 5,800 shares of Class A
common stock was issued to certain
|
||||||||
debenture
holders in the conversion of $580,000 of indebtedness. In
addition, for the redemption of 1,000 shares by certain
debenture
|
||||||||
holders,
the balance due on the debentures was increased by
$600,000.
|
||||||||
During
the six months ended June 30, 2007, the Company received 50 shares of
prior issued common stock
|
||||||||
which
was subsequently cancelled.
|
For
the Three Months Ended
|
||||||||||||
June
30, 2008
|
||||||||||||
As
Originally Stated
|
Adjustments
|
As
Corrected
|
||||||||||
Revenues:
|
||||||||||||
Research
and development
|
$ | - | $ | - | $ | - | ||||||
Revenue
from bridge testing
|
- | - | ||||||||||
Other
|
- | - |
Total
revenues
|
- | - | - | |||||||||||||
Costs
and expenses:
|
||||||||||||||||
Research
and development
|
150,847 | 150,847 | ||||||||||||||
General
and administrative
|
5,517,443 | 5,517,443 | ||||||||||||||
Total
costs and expenses
|
5,668,290 | - | 5,668,290 | |||||||||||||
Loss
from operations
|
(5,668,290 | ) | - | (5,668,290 | ) | |||||||||||
Other
income (expense):
|
||||||||||||||||
Interest
expense
|
(397,973 | ) | 1 | ) | (208,055 | ) | (606,028 | ) | ||||||||
Loss
on modification of convertible debt
|
- | 2 | ) | (964,730 | ) | (964,730 | ) | |||||||||
Change
in fair value of derivative liabilities
|
(6,036,711 | ) | 3 | ) | (65,066,965 | ) | (71,103,676 | ) | ||||||||
Interest
income
|
3,080 | 3,080 | ||||||||||||||
Other
expense, net
|
(6,431,604 | ) | (66,239,750 | ) | (72,671,354 | ) | ||||||||||
Loss
before provision for income taxes
|
(12,099,894 | ) | (66,239,750 | ) | (78,339,644 | ) | ||||||||||
Provision
for income taxes
|
- | - | - | |||||||||||||
Net
loss
|
$ | (12,099,894 | ) | $ | (66,239,750 | ) | $ | (78,339,644 | ) | |||||||
Per
share data:
|
||||||||||||||||
Basic
and diluted net loss per share
|
$ | (77.26 | ) | $ | (422.94 | ) | $ | (500.20 | ) | |||||||
|
||||||||||||||||
Weighted average
Class A common shares outstanding - basic and
diluted
|
156,617 | 156,617 | 156,617 |
1) To
record additional interest of $16,597 on the increased balance of debt
and
amortization of increased discount totalling
$191,458.
|
2)
To record loss on modification of convertible debt.
|
3) To
expense increase in derivative liability due to the reduction in conversion price of
convertible debt and granting of warrants to purchase 35M shares of common
stock.
|
For
the Six Months Ended
|
||||||||||||||||
June
30, 2008
|
||||||||||||||||
As
Originally Stated
|
Adjustments
|
As
Corrected
|
||||||||||||||
Revenues:
|
||||||||||||||||
Research
and development
|
$ | - | - | $ | - | |||||||||||
Revenue
from bridge testing
|
1,090 | - | 1,090 | |||||||||||||
Other
|
- | - | - | |||||||||||||
Total
revenues
|
1,090 | - | 1,090 | |||||||||||||
Costs
and expenses:
|
||||||||||||||||
Research
and development
|
309,840 | 309,840 | ||||||||||||||
General
and administrative
|
25,845,768 | 25,845,768 | ||||||||||||||
Total
costs and expenses
|
26,155,608 | - | 26,155,608 | |||||||||||||
Loss
from operations
|
(26,154,518 | ) | - | (26,154,518 | ) | |||||||||||
Other
income (expense):
|
||||||||||||||||
Interest
expense
|
(768,964 | ) | 1 | ) | (208,055 | ) | (977,019 | ) | ||||||||
Loss
on modification of convertible debt
|
- | 2 | ) | (964,730 | ) | (964,730 | ) | |||||||||
Change
in fair value of derivative liabilities
|
||||||||||||||||
Interest
income
|
- | |||||||||||||||
Other
expense, net
|
- | - | ||||||||||||||
Net
unrealized and realized loss of marketable securities
|
(8 | ) | (8 | ) | ||||||||||||
Change
in fair value of derivative liabilities
|
2,522,864 | 3 | ) | (65,066,965 | ) | (62,544,101 | ) | |||||||||
Interest
income
|
15,523 | 15,523 | ||||||||||||||
1,769,415 | (66,239,750 | ) | (64,470,335 | ) | ||||||||||||
Loss
before provision for income taxes
|
(24,385,103 | ) | (66,239,750 | ) | (90,624,853 | ) | ||||||||||
Provision
for income taxes
|
(800 | ) | - | (800 | ) | |||||||||||
Net
loss
|
$ | (28,200,501 | ) | $ | (66,239,750 | ) | $ | (90,625,653 | ) | |||||||
Per
share data:
|
||||||||||||||||
Basic
and diluted net loss per share
|
$ | (0.31 | ) | $ | (723.63 | ) | $ | (990.04 | ) | |||||||
|
||||||||||||||||
Weighted
average Class A common shares outstanding - basic and
diluted
|
91,538 | 91,538 | 91,538 |
1) To
record additional interest of $16,597 on the increased balance of debt and
amortization
of increased discount totaling
$191,458.
|
2)
To record loss on modification of convertible debt.
|
3) To
expense increase in derivative liability due to the reduction in
conversion price of convertible debt and
granting of warrants to purchase 35M shares of common
stock.
|